Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.07 | N/A | +88.20% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.07 | N/A | +88.20% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management conveyed a cautiously optimistic outlook, highlighting the importance of technology investments. They are focused on long-term growth despite the lack of revenue guidance.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They emphasized ongoing investments in technology and customer engagement.
The focus remains on long-term growth and improving service offerings.
Teladoc's earnings report showed a significant positive surprise in EPS, which contributed to a slight increase in stock price. However, the absence of revenue figures and guidance leaves some uncertainty about the company's immediate financial outlook. Investors may be encouraged by the EPS beat but will likely look for more clarity in future reports.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AGILENT TECHNOLOGIES
Feb 22, 2022